Your shopping cart is currently empty

Leukotriene D4-d5 is a deuterated form of Leukotriene D4. Leukotriene D4 is one of the components of the slow-reacting substance of anaphylaxis (SRS-A), produced from LTC4 by the metabolism of γ-glutamyl transpeptidase. It is the first cysteinyl leukotriene metabolite of LTC4. The bronchoconstriction and increased vascular permeability induced by Leukotriene D4 contribute to the pathogenesis of asthma and acute hypersensitivity reactions.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Leukotriene D4-d5 is a deuterated form of Leukotriene D4. Leukotriene D4 is one of the components of the slow-reacting substance of anaphylaxis (SRS-A), produced from LTC4 by the metabolism of γ-glutamyl transpeptidase. It is the first cysteinyl leukotriene metabolite of LTC4. The bronchoconstriction and increased vascular permeability induced by Leukotriene D4 contribute to the pathogenesis of asthma and acute hypersensitivity reactions. |
| Molecular Weight | 501.69 |
| Formula | C25H40N2O6S |
| Cas No. | 1240398-17-7 |
| Smiles | [C@H](SC[C@@H](C(NCC(O)=O)=O)N)([C@H](CCCC(O)=O)O)/C=C/C=C/C=C\C/C=C\CCCC(C([2H])([2H])[2H])([2H])[2H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.